This guidance sets out the circumstances in which it may be appropriate to offer a course of prophylactic antiviral medicine to patients with a serious underlying medical condition or who are pregnant during the H1N1 (swine flu) pandemic.
Related articles
-
HSJ KnowledgePartnership working and the flu pandemic
The H1N1 pandemic never reached the intensity feared, but the emergency response set in place has strengthened partnership working.
-
NewsSwine flu vaccine bill cost department £239m
The government spent £239m on the swine flu vaccine, official figures reveal.
-
NewsRise in intensive care beds occupied by flu patients
The number of flu cases being treated in critical care beds has increased by 66 per cent in the last week, according to figures released by the Department of Health.
More from News
-
NewsFirm drops challenge to £70m IT contract
A software company has dropped its legal challenge against a major trust’s £70m electronic patient record purchase.
-
NewsNew chief for world-famous hospital
Great Ormond Street Hospital for Children has announced its new chief executive.
-
NewsNHS cyber security boss steps down
NHS England’s head of cyber security is leaving after a challenging period for the sector.
No comments yet